Musculoskeletal gene therapy and its potential use in the treatment of complicated musculoskeletal infection.
Tissue repair is a major issue in orthopedics. Many musculoskeletal tissues, including cartilage, meniscus, and the anterior cruciate ligament, heal poorly after injury. Recent studies have led to the identification of numerous growth factors and other gene products that can promote the regeneration of damaged musculoskeletal tissues. In the last century, the discovery and evolving use of antibiotics has significantly decreased the prevalence and severity of infectious diseases. In many orthopedic scenarios, however, treatment of infections can be difficult, and often involves a prolonged course of antibiotics with concomitant surgical interventions and loss of tissue. Although studies have demonstrated the successful transfer of target genes and the associated manipulation of the musculoskeletal tissue environment, researchers have made few attempts designed to use gene therapy to treat infectious musculoskeletal diseases in animal models. Before it is possible to use gene-based approaches to treat such diseases effectively, researchers must perform more studies to investigate the potential problems that may arise when using gene therapy in an infectious environment.
Shen
Wei
W
Growth and Development Laboratory of Children's Hospital of Pittsburgh, 4100 Rangos Research Center, Pittsburgh, PA 15213-2583, USA.
Li
Yong
Y
Huard
Johnny
J
D001847:Bone Diseases / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends*; D006801:Humans; D009135:Muscular Diseases / Q000235:genetics* / Q000473:pathology / Q000628:therapy*